Add to Favorites Newsroom RSS Share
fb-shareMoffitt Cancer Center
Tampa, FL USA

Our News on Newswise

Moffitt Researchers Identify a Mechanism Controlling Tumor Cell Recognition by Immune Cells

Immunotherapy has become a standard treatment approach for several types of cancer, including melanoma. However, tumors can escape immune cell detection even with the use of immunotherapies. In a new study published in Cancer Immunology Research,...
1-Nov-2019 10:30 AM EDT Add to Favorites

Melanoma Variability at the Single-Cell Level Predicts Treatment Responses, Say Moffitt Researchers

In a new study published in EBioMedicine, researchers with Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence reveal that differences at the single-cell level can predict responses to initial BRAF inhibitor...
8-Oct-2019 10:30 AM EDT Add to Favorites

Moffitt Cancer Center Researchers Identify Mechanism Controlling DNA Repair

Moffitt Cancer Center researchers recently identified a new mechanism that controls DNA repair.
2-Oct-2019 11:10 AM EDT Add to Favorites

New Drug Combination Shows Promising Activity in Non-Small Cell Lung Cancer Patients

Patients with non-small cell lung cancer (NSCLC) now have more improved treatment options compared to standard of care with the addition of several new agents called immune-checkpoint inhibitors (ICI). Despite these changes, many patients still...
27-Aug-2019 9:00 AM EDT Add to Favorites

Moffitt Researchers Develop Model to Personalize Radiation Treatment for Breast Cancer Patients

A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns. However, this same personalized strategy has...
22-Aug-2019 10:50 AM EDT Add to Favorites

Moffitt Researchers Complete Largest Genomic Analysis of Merkel Cell Carcinoma Patients

Merkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each year in the United States. Since MCC affects so few people, it is difficult to study the genetic factors that lead to its development...
20-Aug-2019 10:30 AM EDT Add to Favorites

Moffitt Researchers Discover Possible New Treatment Strategy for Lung Cancer

Lung cancer is the second most common cancer found in both men and women. It is estimated there will be roughly 228,000 new lung cancer cases this year, and nearly 30% of those patients will have mutations in the KRAS pathway. This type of mutation...
19-Aug-2019 2:00 PM EDT Add to Favorites

Moffitt Researchers Identify Subtypes of Squamous Cell Lung Cancer

Despite improved knowledge of the molecular alterations in SCC, little is understood about how the alterations contribute to the development of the cancer and how potential vulnerabilities could be exploited to treat the disease. Researchers in...
8-Aug-2019 10:00 AM EDT Add to Favorites


see all news

Our Experts on Newswise

Newswise: AnnaGiuliano_Euroginopeningtalk_2017.jpg

Moffitt Cancer Center HPV Expert Kicked Off EUROGIN Conference

Anna Giuliano, Ph.D., director of Moffitt Cancer Center’s Center for Infection Research in Cancer, delivered the opening keynote address at the 2017 European Research Organization on Genital Infection and Neoplasia (EUROGIN) International...
10-Oct-2017 10:05 AM EDT

see all experts

Our YouTube Videos

About

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 50 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 6,000 team members, Moffitt has an economic impact in the state of $2.5 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube.

Contacts

Kim Polacek
Senior Public Relations Account Coordinator

Kim.Polacek@Moffitt.org

813-745-7408

Steven Blanchard
Public Relations Account Coordinator

Steven.Blanchard@Moffitt.org

813-745-1718

Sara Bondell
Public Relations Account Coodinator

Sara.Bondell@moffitt.org

813-745-1353

Patty Kim
Public Relations Manager

Patty.Kim@Moffitt.org

813-745-7322

Twitter twitter-icon

Chat now!
0.74088